Products
Platform
Research
Market
Learn
Beryl Drugs Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 4.73 | 3.63 | 3.24 | 4.88 | 2.51 |
| Other Income Qtr Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenues Qtr | 4.73 | 3.63 | 3.24 | 4.88 | 2.51 |
Loading chart... | |||||
Operating Expenses Qtr | 3.81 | 3.38 | 2.99 | 4.68 | 2.39 |
Operating Profit Qtr | 0.93 | 0.25 | 0.25 | 0.20 | 0.12 |
EBITDA Qtr Cr | 0.93 | 0.25 | 0.70 | 0.20 | 0.12 |
Depreciation Qtr | -0.05 | 0.10 | 0.10 | 0.10 | 0.08 |
Net Profit Qtr | 0.88 | 0.10 | 0.54 | 0.03 | -0.02 |
Basic EPS Qtr | 1.73 | 0.20 | 0.16 | 0.07 | -0.04 |
Open Demat Account
Open Demat Account